{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:06:01Z","timestamp":1790845561205,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00428-022-03283-x","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T16:02:57Z","timestamp":1643644977000},"page":"999-1008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Low-grade oncocytic tumor of kidney harboring TSC\/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity"],"prefix":"10.1007","volume":"480","author":[{"given":"Hui-Zhi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Yuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"3283_CR1","doi-asserted-by":"crossref","unstructured":"Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors (2016) WHO classification of tumours of the urinary system and male genital organs. 4th ed. Lyon","DOI":"10.1016\/j.eururo.2016.02.029"},{"key":"3283_CR2","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","volume":"34","author":"K Trpkov","year":"2021","unstructured":"Trpkov K, Williamson SR, Gill AJ et al (2021) Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol 34:1167\u20131184. https:\/\/doi.org\/10.1038\/s41379-021-00737-6","journal-title":"Mod Pathol"},{"key":"3283_CR3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00292-021-00998-7","volume":"41","author":"K Trpkov","year":"2017","unstructured":"Trpkov K, Abou-Ouf H, Hes O et al (2017) Eosinophilic solid and cystic renal cell carcinoma (ESC RCC): further morphologic and molecular characterization of ESC RCC as a distinct entity. Am J Surg Pathol 41:1299\u20131308. https:\/\/doi.org\/10.1007\/s00292-021-00998-7","journal-title":"Am J Surg Pathol"},{"key":"3283_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","volume":"74","author":"R Mehra","year":"2018","unstructured":"Mehra R, Vats P, Cao X et al (2018) Somatic bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma. Eur Urol 74:483\u2013486. https:\/\/doi.org\/10.1016\/j.eururo.2018.06.007","journal-title":"Eur Urol"},{"key":"3283_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/PAS.0000000000001067","volume":"42","author":"M Parilla","year":"2018","unstructured":"Parilla M, Kadri S, Patil SA et al (2018) Are sporadic eosinophilic solid and cystic renal cell carcinomas characterized by somatic tuberous sclerosis gene mutations? Am J Surg Pathol 42:911\u2013917. https:\/\/doi.org\/10.1097\/PAS.0000000000001067","journal-title":"Am J Surg Pathol"},{"key":"3283_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","volume":"43","author":"YB Chen","year":"2019","unstructured":"Chen YB, Mirsadraei L, Jayakumaran G et al (2019) Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm. Am J Surg Pathol 43:121\u2013131. https:\/\/doi.org\/10.1097\/PAS.0000000000001170","journal-title":"Am J Surg Pathol"},{"key":"3283_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/PAP.0000000000000299","volume":"28","author":"P Kapur","year":"2021","unstructured":"Kapur P, Gao M, Zhong H et al (2021) Eosinophilic vacuolated tumor of the kidney: a review of evolving concepts in this novel subtype with additional insights from a case with mTOR mutation and concomitant chromosome 1 Loss. Adv Anat Pathol 28:251\u2013257. https:\/\/doi.org\/10.1097\/PAP.0000000000000299","journal-title":"Adv Anat Pathol"},{"key":"3283_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00923-6","author":"M Farca\u015f","year":"2021","unstructured":"Farca\u015f M, Gatalica Z, Trpkov K et al (2021) Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC\/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-021-00923-6","journal-title":"Mod Pathol"},{"key":"3283_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/his.13865","volume":"75","author":"K Trpkov","year":"2019","unstructured":"Trpkov K, Williamson SR, Gao Y et al (2019) Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity? Histopathology 75:174\u2013184. https:\/\/doi.org\/10.1111\/his.13865","journal-title":"Histopathology"},{"key":"3283_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/his.13727","volume":"74","author":"K Trpkov","year":"2019","unstructured":"Trpkov K, Hes O (2019) New and emerging renal entities: a perspective post-WHO 2016 classification. Histopathology 74:31\u201359. https:\/\/doi.org\/10.1111\/his.13727","journal-title":"Histopathology"},{"key":"3283_CR11","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3390\/cancers12010168","volume":"12","author":"F Siadat","year":"2020","unstructured":"Siadat F, Trpkov K (2020) ESC, ALK, HOT and LOT: three letter acronyms of emerging renal entities knocking on the door of the WHO classification. Cancers (Basel) 12:168. https:\/\/doi.org\/10.3390\/cancers12010168","journal-title":"Cancers (Basel)"},{"key":"3283_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.118","volume":"10","author":"J Li","year":"2020","unstructured":"Li J, Wei Q, Wu X et al (2020) Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response. Clin Transl Med 10:e118. https:\/\/doi.org\/10.1002\/ctm2.118","journal-title":"Clin Transl Med"},{"key":"3283_CR13","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen R, Seshan VE (2016) FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res 44:e131. https:\/\/doi.org\/10.1093\/nar\/gkw520","journal-title":"Nucleic Acids Res"},{"key":"3283_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humpath.2021.04.013","volume":"114","author":"O Kravtsov","year":"2021","unstructured":"Kravtsov O, Gupta S, Cheville JC et al (2021) Low-grade oncocytic tumor of kidney (CK7-Positive, CD117-Negative): incidence in a single institutional experience with clinicopathological and molecular characteristics. Hum Pathol 114:9\u201318. https:\/\/doi.org\/10.1016\/j.humpath.2021.04.013","journal-title":"Hum Pathol"},{"key":"3283_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00428-020-02927-0","volume":"478","author":"Q Guo","year":"2021","unstructured":"Guo Q, Liu N, Wang F et al (2021) Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China. Virchows Arch 478:449\u2013458. https:\/\/doi.org\/10.1007\/s00428-020-02927-0","journal-title":"Virchows Arch"},{"key":"3283_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2021-207478","author":"M Akgul","year":"2021","unstructured":"Akgul M, Al-Obaidy KI, Cheng L et al (2021) Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute. J Clin Pathol. https:\/\/doi.org\/10.1136\/jclinpath-2021-207478","journal-title":"J Clin Pathol"},{"key":"3283_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00969-6","author":"SK Mohanty","year":"2021","unstructured":"Mohanty SK, Satapathy A, Aggarwal A et al (2021) Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-021-00969-6","journal-title":"Mod Pathol"},{"key":"3283_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00896-6","author":"P Kapur","year":"2021","unstructured":"Kapur P, Gao M, Zhong H et al (2021) Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-021-00896-6","journal-title":"Mod Pathol"},{"key":"3283_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2021.09.010","author":"S Gupta","year":"2021","unstructured":"Gupta S, Rowsey RA, Cheville JC et al (2021) Morphologic overlap between low-grade oncocytic tumor and eosinophilic variant of chromophobe renal cell carcinoma. Hum Pathol. https:\/\/doi.org\/10.1016\/j.humpath.2021.09.010","journal-title":"Hum Pathol"},{"key":"3283_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-021-00906-7","author":"A Morini","year":"2021","unstructured":"Morini A, Drossart T, Timsit MO et al (2021) Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1. Mod Pathol. https:\/\/doi.org\/10.1038\/s41379-021-00906-7","journal-title":"Mod Pathol"},{"key":"3283_CR21","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/cancers11101492","volume":"11","author":"R Ohashi","year":"2019","unstructured":"Ohashi R, Schraml P, Angori S et al (2019) Classic chromophobe renal cell carcinoma incur a larger number of chromosomal losses than seen in the eosinophilic subtype. Cancers (Basel) 11:1492. https:\/\/doi.org\/10.3390\/cancers11101492","journal-title":"Cancers (Basel)"},{"key":"3283_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.humpath.2020.12.006","volume":"115","author":"MY Tjota","year":"2021","unstructured":"Tjota MY, Wanjari P, Segal J et al (2021) TSC\/MTOR mutated eosinophilic renal tumors are a distinct entity that are CK7+\/CK20-\/vimentin-: a validation study. Hum Pathol 115:84\u201395. https:\/\/doi.org\/10.1016\/j.humpath.2020.12.006","journal-title":"Hum Pathol"},{"key":"3283_CR23","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1442-2042.2010.02574.x","volume":"17","author":"MV Yusenko","year":"2010","unstructured":"Yusenko MV (2010) Molecular pathology of renal oncocytoma: a review. Int J Urol 17:602\u2013612. https:\/\/doi.org\/10.1111\/j.1442-2042.2010.02574.x","journal-title":"Int J Urol"},{"key":"3283_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.eururo.2020.03.003","volume":"78","author":"SL Skala","year":"2020","unstructured":"Skala SL, Wang X, Zhang Y et al (2020) Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms. Eur Urol 78:63\u201374. https:\/\/doi.org\/10.1016\/j.eururo.2020.03.003","journal-title":"Eur Urol"},{"key":"3283_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","volume":"26","author":"CF Davis","year":"2014","unstructured":"Davis CF, Ricketts CJ, Wang M et al (2014) The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell 26:319\u2013330. https:\/\/doi.org\/10.1016\/j.ccr.2014.07.014","journal-title":"Cancer Cell"},{"key":"3283_CR26","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.mayocp.2020.11.004","volume":"96","author":"S Gupta","year":"2021","unstructured":"Gupta S, Jimenez RE, Herrera-Hernandez L et al (2021) Renal neoplasia in tuberous sclerosis: a study of 41 patients. Mayo Clin Proc 96:1470\u20131489. https:\/\/doi.org\/10.1016\/j.mayocp.2020.11.004","journal-title":"Mayo Clin Proc"},{"key":"3283_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2021.06.002","volume":"116","author":"LA Lerma","year":"2021","unstructured":"Lerma LA, Schade GR, Tretiakova MS (2021) Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex. Hum Pathol 116:1\u201311. https:\/\/doi.org\/10.1016\/j.humpath.2021.06.002","journal-title":"Hum Pathol"},{"key":"3283_CR28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","volume":"44","author":"M Tjota","year":"2020","unstructured":"Tjota M, Chen H, Parilla M et al (2020) Eosinophilic renal cell tumors with a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous clinicopathologic and molecular study. Am J Surg Pathol 44:943\u2013954. https:\/\/doi.org\/10.1097\/PAS.0000000000001457","journal-title":"Am J Surg Pathol"},{"key":"3283_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00428-020-02900-x","volume":"478","author":"K Tong","year":"2021","unstructured":"Tong K, Hu Z (2021) FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry. Virchows Arch 478:647\u2013658. https:\/\/doi.org\/10.1007\/s00428-020-02900-x","journal-title":"Virchows Arch"},{"key":"3283_CR30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.pathol.2020.10.013","volume":"53","author":"MY Tjota","year":"2021","unstructured":"Tjota MY, Segal J, Stadler WM et al (2021) Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case. Pathology 53:790\u2013793. https:\/\/doi.org\/10.1016\/j.pathol.2020.10.013","journal-title":"Pathology"},{"key":"3283_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/his.13395","volume":"72","author":"Y Li","year":"2018","unstructured":"Li Y, Reuter VE, Matoso A et al (2018) Re-evaluation of 33 \u2018unclassifified\u2019 eosinophilic renal cell carcinomas in young patients. Histopathology 72:588\u2013600. https:\/\/doi.org\/10.1111\/his.13395","journal-title":"Histopathology"},{"key":"3283_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.humpath.2018.05.023","volume":"80","author":"MS Tretiakova","year":"2018","unstructured":"Tretiakova MS (2018) Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases. HumPathol 80:65\u201375. https:\/\/doi.org\/10.1016\/j.humpath.2018.05.023","journal-title":"HumPathol"},{"key":"3283_CR33","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/his.13457","volume":"72","author":"JK McKenney","year":"2018","unstructured":"McKenney JK, Przybycin CG, Trpkov K et al (2018) Eosinophilic solid and cystic renal cell carcinomas have metastatic potential. Histopathology 72:1066\u20131067. https:\/\/doi.org\/10.1111\/his.13457","journal-title":"Histopathology"},{"key":"3283_CR34","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","volume":"42","author":"DN Palsgrove","year":"2018","unstructured":"Palsgrove DN, Li Y, Pratilas CA et al (2018) Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations molecular analysis supports an expanding clinicopathologic spectrum. Am J Surg Pathol 42:1166\u20131181. https:\/\/doi.org\/10.1097\/PAS.0000000000001111","journal-title":"Am J Surg Pathol"},{"key":"3283_CR35","doi-asserted-by":"publisher","first-page":"151788","DOI":"10.1016\/j.anndiagpath.2021.151788","volume":"54","author":"H Karatay","year":"2021","unstructured":"Karatay H, Ozluk Y, Dogan MA et al (2021) Immunoexpression of SDHB, FH, and CK20 among eosinophilic renaltumors: A tissue microarray study. Ann Diagn Pathol 54:151788. https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151788","journal-title":"Ann Diagn Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03283-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03283-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03283-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T05:08:36Z","timestamp":1650604116000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03283-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3283"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03283-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}